Truist Securities Initiates Coverage On Ardent Health Partners with Buy Rating, Announces Price Target of $21
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has initiated coverage on Ardent Health Partners (NYSE: ARDT) with a Buy rating and a price target of $21.
August 12, 2024 | 10:32 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Truist Securities has initiated coverage on Ardent Health Partners with a Buy rating and a price target of $21.
The initiation of coverage with a Buy rating and a specific price target of $21 by Truist Securities is likely to positively impact the stock price of Ardent Health Partners in the short term. Analyst ratings and price targets are significant indicators for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100